Jul 13, 2026 04:00AM
Jul 13, 2026 04:00AM
Jul 6, 2026 08:39AM
Jul 6, 2026 08:39AM
Jun 26, 2026 09:00AM
Jun 26, 2026 09:00AM
Jun 19, 2026 02:00AM Incyte Japan Announces Approval of Minjuvi® (tafasitamab) in Combination with Lenalidomide for the Treatment of Adults with Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Jun 15, 2026 09:24AM
Jun 14, 2026 04:35PM
Jun 14, 2026 04:35PM
Jun 13, 2026 06:01AM
Jun 13, 2026 06:00AM
Jun 8, 2026 07:00AM
Jun 8, 2026 07:00AM Incyte to Acquire Vega Therapeutics, a Wholly Owned Subsidiary of Star Therapeutics, Expanding its Hematology Portfolio into Bleeding Disorders
Jun 4, 2026 08:06AM
Jun 4, 2026 08:05AM
Jun 1, 2026 02:53AM
May 30, 2026 08:00AM
May 12, 2026 09:30AM
May 7, 2026 08:50AM
May 7, 2026 08:50AM Incyte Announces 24-Week Long-Term Data from Phase 3 TRuE-AD4 Trial of Opzelura® (ruxolitinib) Cream in Adults with Moderate Atopic Dermatitis
May 3, 2026 12:00PM
May 1, 2026 05:28PM
May 1, 2026 05:28PM
Apr 29, 2026 10:15AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM
Apr 28, 2026 07:00AM Incyte Reports First Quarter 2026 Financial Results and Provides Business Updates
Apr 23, 2026 05:48AM
Apr 23, 2026 03:00AM
Apr 21, 2026 10:00AM
Apr 21, 2026 10:00AM
Apr 7, 2026 12:26PM
Apr 7, 2026 07:30AM
Apr 2, 2026 07:01AM Adagene partners with Incyte for cancer drug combination study
Apr 2, 2026 07:01AM
Mar 30, 2026 10:19AM
Mar 30, 2026 04:21AM
Mar 28, 2026 03:00PM
Mar 25, 2026 09:13AM
Mar 24, 2026 04:02PM
Mar 20, 2026 10:00AM Incyte to Highlight Late-Breaking Hidradenitis Suppurativa Data at the 2026 American Academy of Dermatology (AAD) Annual Meeting
Mar 17, 2026 07:30AM
Mar 17, 2026 07:30AM
Mar 9, 2026 08:00AM
Feb 27, 2026 08:13AM
Feb 27, 2026 08:11AM
Feb 19, 2026 05:31PM
Feb 17, 2026 10:48AM Registration Momentum Builds Across the Oncology Pipeline
Feb 16, 2026 05:31PM

325,901 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All